Cargando…

Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling

The cellular and molecular mechanisms by which adrenomedullin (AM) blockade suppresses tumor neovessels are not well defined. Herein, we show that AM blockade using anti-AM and anti-AM receptors antibodies targets vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs), and induces...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalfaoui-Bendriss, Ghizlane, Dussault, Nadège, Fernandez-Sauze, Samantha, Berenguer-Daizé, Caroline, Sigaud, Romain, Delfino, Christine, Cayol, Mylène, Metellus, Philippe, Chinot, Olivier, Mabrouk, Kamel, Martin, Pierre-Marie, Ouafik, L'Houcine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480698/
https://www.ncbi.nlm.nih.gov/pubmed/25924235
_version_ 1782378175929516032
author Khalfaoui-Bendriss, Ghizlane
Dussault, Nadège
Fernandez-Sauze, Samantha
Berenguer-Daizé, Caroline
Sigaud, Romain
Delfino, Christine
Cayol, Mylène
Metellus, Philippe
Chinot, Olivier
Mabrouk, Kamel
Martin, Pierre-Marie
Ouafik, L'Houcine
author_facet Khalfaoui-Bendriss, Ghizlane
Dussault, Nadège
Fernandez-Sauze, Samantha
Berenguer-Daizé, Caroline
Sigaud, Romain
Delfino, Christine
Cayol, Mylène
Metellus, Philippe
Chinot, Olivier
Mabrouk, Kamel
Martin, Pierre-Marie
Ouafik, L'Houcine
author_sort Khalfaoui-Bendriss, Ghizlane
collection PubMed
description The cellular and molecular mechanisms by which adrenomedullin (AM) blockade suppresses tumor neovessels are not well defined. Herein, we show that AM blockade using anti-AM and anti-AM receptors antibodies targets vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs), and induces regression of unstable nascent tumor neovessels. The underlying mechanism involved, and shown in vitro and in vivo in mice, is the disruption of the molecular engagement of the endothelial cell-specific junctional molecules vascular endothelial-cadherin (VE-cadherin)/β-catenin complex. AM blockade increases endothelial cell permeability by inhibiting cell-cell contacts predominantly through disruption of VE-cadherin/β-catenin/Akt signalling pathway, thereby leading to vascular collapse and regression of tumor neovessels. At a molecular level, we show that AM blockade induces tyrosine phosphorylation of VE-cadherin at a critical tyrosine, Tyr(731), which is sufficient to prevent the binding of β-catenin to the cytoplasmic tail of VE-cadherin leading to the inhibition of cell barrier function. Furthermore, we demonstrate activation of Src kinase by phosphorylation on Tyr(416), supporting a role of Src to phosphorylate Tyr(731)-VE-cadherin. In this model, Src inhibition impairs αAM and αAMR-induced Tyr(731)-VE-cadherin phosphorylation in a dose-dependent manner, indicating that Tyr(731)-VE-cadherin phosphorylation state is dependent on Src activation. We found that AM blockade induces β-catenin phosphorylation on Ser(33)/Ser(37)/Thr(41) sites in both ECs and VSMCs both in vitro and in vivo in mice. These data suggest that AM blockade selectively induces regression of unstable tumor neovessels, through disruption of VE-cadherin signalling. Targeting AM system may present a novel therapeutic target to selectively disrupt assembly and induce regression of nascent tumor neovessels, without affecting normal stabilized vasculature.
format Online
Article
Text
id pubmed-4480698
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-44806982015-06-26 Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling Khalfaoui-Bendriss, Ghizlane Dussault, Nadège Fernandez-Sauze, Samantha Berenguer-Daizé, Caroline Sigaud, Romain Delfino, Christine Cayol, Mylène Metellus, Philippe Chinot, Olivier Mabrouk, Kamel Martin, Pierre-Marie Ouafik, L'Houcine Oncotarget Research Paper The cellular and molecular mechanisms by which adrenomedullin (AM) blockade suppresses tumor neovessels are not well defined. Herein, we show that AM blockade using anti-AM and anti-AM receptors antibodies targets vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs), and induces regression of unstable nascent tumor neovessels. The underlying mechanism involved, and shown in vitro and in vivo in mice, is the disruption of the molecular engagement of the endothelial cell-specific junctional molecules vascular endothelial-cadherin (VE-cadherin)/β-catenin complex. AM blockade increases endothelial cell permeability by inhibiting cell-cell contacts predominantly through disruption of VE-cadherin/β-catenin/Akt signalling pathway, thereby leading to vascular collapse and regression of tumor neovessels. At a molecular level, we show that AM blockade induces tyrosine phosphorylation of VE-cadherin at a critical tyrosine, Tyr(731), which is sufficient to prevent the binding of β-catenin to the cytoplasmic tail of VE-cadherin leading to the inhibition of cell barrier function. Furthermore, we demonstrate activation of Src kinase by phosphorylation on Tyr(416), supporting a role of Src to phosphorylate Tyr(731)-VE-cadherin. In this model, Src inhibition impairs αAM and αAMR-induced Tyr(731)-VE-cadherin phosphorylation in a dose-dependent manner, indicating that Tyr(731)-VE-cadherin phosphorylation state is dependent on Src activation. We found that AM blockade induces β-catenin phosphorylation on Ser(33)/Ser(37)/Thr(41) sites in both ECs and VSMCs both in vitro and in vivo in mice. These data suggest that AM blockade selectively induces regression of unstable tumor neovessels, through disruption of VE-cadherin signalling. Targeting AM system may present a novel therapeutic target to selectively disrupt assembly and induce regression of nascent tumor neovessels, without affecting normal stabilized vasculature. Impact Journals LLC 2015-02-05 /pmc/articles/PMC4480698/ /pubmed/25924235 Text en Copyright: © 2015 Khalfaoui-Bendriss et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Khalfaoui-Bendriss, Ghizlane
Dussault, Nadège
Fernandez-Sauze, Samantha
Berenguer-Daizé, Caroline
Sigaud, Romain
Delfino, Christine
Cayol, Mylène
Metellus, Philippe
Chinot, Olivier
Mabrouk, Kamel
Martin, Pierre-Marie
Ouafik, L'Houcine
Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling
title Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling
title_full Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling
title_fullStr Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling
title_full_unstemmed Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling
title_short Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling
title_sort adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480698/
https://www.ncbi.nlm.nih.gov/pubmed/25924235
work_keys_str_mv AT khalfaouibendrissghizlane adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling
AT dussaultnadege adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling
AT fernandezsauzesamantha adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling
AT berenguerdaizecaroline adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling
AT sigaudromain adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling
AT delfinochristine adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling
AT cayolmylene adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling
AT metellusphilippe adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling
AT chinotolivier adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling
AT mabroukkamel adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling
AT martinpierremarie adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling
AT ouafiklhoucine adrenomedullinblockadeinducesregressionoftumorneovesselsthroughinterferencewithvascularendothelialcadherinsignalling